Viewing Study NCT06302660


Ignite Creation Date: 2025-12-25 @ 2:04 AM
Ignite Modification Date: 2025-12-26 @ 1:58 AM
Study NCT ID: NCT06302660
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-01-27
First Post: 2024-03-04
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Profiling Microbiome Associated Metabolic Pathways in Oesophageal Cancer Survivors
Sponsor: Imperial College London
Organization:

Study Overview

Official Title: Profiling Microbiome Associated Metabolic Pathways in Oesophageal Cancer Survivors
Status: ACTIVE_NOT_RECRUITING
Status Verified Date: 2025-01
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: MAPLES
Brief Summary: The goal of this observational study is to learn about long term symptoms in oesophageal cancer survivors. The main question it aims to answer is are:

* Study the changes in gut bacteria by examining saliva, stool and blood.
* Investigate the products of bacteria in breath to develop a non-invasive breath test to detect the changes in gut bacteria.
* Develop new strategies to treat this change and trial new treatments to improve quality- of-life in oesophageal cancer survivors.

Participants will attend an outpatient clinic, fasted for at least 4 hours for collection of breath, saliva, blood, urine, stool and complete validated healthy-related quality-of-life questionnaires.

Researchers will compare symptomatic and asymptomatic participants to detect the changes stated above.
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: